Considering the APOE locus in Alzheimer's disease polygenic scores in the Health and Retirement Study: a longitudinal panel study

被引:14
|
作者
Ware, Erin B. [1 ]
Faul, Jessica D. [1 ]
Mitchell, Colter M. [1 ]
Bakulski, Kelly M. [2 ]
机构
[1] Univ Michigan, Inst Social Res, Survey Res Ctr, 426 Thompson St,Rm 3320 ISR Thompson, Ann Arbor, MI 48104 USA
[2] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Polygenic score; Alzheimer’ s disease; Dementia; Apolipoprotein E; P-value; Thresholding; GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; RISK SCORE; VARIANTS; ARCHITECTURE; METAANALYSIS; TAU;
D O I
10.1186/s12920-020-00815-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Polygenic scores are a strategy to aggregate the small, additive effects of single nucleotide polymorphisms across the genome. With phenotypes like Alzheimer's disease, which have a strong and well-established genomic locus (APOE), the cumulative effect of genetic variants outside of this area has not been well established in a population-representative sample. Methods Here we examine the association between polygenic scores for Alzheimer's disease both with and without the APOE region (chr19: 45,384,477 to 45,432,606, build 37/hg 19) at different P value thresholds and dementia. We also investigate the addition of APOE-epsilon 4 carrier status and its effect on the polygenic score-dementia association in the Health and Retirement Study using generalized linear models accounting for repeated measures by individual and use a binomial distribution, logit link, and unstructured correlation structure. Results In a large sample of European ancestry participants of the Health and Retirement Study (n = 9872) with an average of 5.2 (standard deviation 1.8) visit spaced two years apart, we found that including the APOE region through weighted variants in a polygenic score was insufficient to capture the large amount of risk attributed to this region. We also found that a polygenic score with a P value threshold of 0.01 had the strongest association with the odds of dementia in this sample (odds ratio = 1.10 95%CI 1.0 to 1.2). Conclusion We recommend removing the APOE region from polygenic score calculation and treating the APOE locus as an independent covariate when modeling dementia. We also recommend using a moderately conservative P value threshold (e.g. 0.01) when creating polygenic scores for Alzheimer's disease on dementia. These recommendations may help elucidate relationships between polygenic scores and regions of strong significance for phenotypes similar to Alzheimer's disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] COMMUNITY CAPACITY AND ELDER'S HEALTH OUTCOMES: THE CHINA HEALTH AND RETIREMENT LONGITUDINAL STUDY
    Du, Y.
    Xu, Q.
    GERONTOLOGIST, 2016, 56 : 137 - 137
  • [42] APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study
    Camarda, Cecilia
    Torelli, Paola
    Pipia, Carmela
    Sottile, Gianluca
    Cilluffo, Giovanna
    Camarda, Rosolino
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (08) : 766 - 780
  • [43] Phenome-Wide Association Study of Polygenic Risk Score for Alzheimer's Disease in Electronic Health Records
    Fu, Mingzhou
    Chang, Timothy S.
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [44] Awareness of disease in Alzheimer's disease: preliminary results of a longitudinal study
    Barroso de Sousa, Maria Fernanda
    Santos, Raquel Luiza
    Arcoverde, Cynthia
    Dourado, Marcia
    Laks, Jerson
    REVISTA DE PSIQUIATRIA CLINICA, 2011, 38 (02): : 57 - 60
  • [45] Enhancing the utility of polygenic scores in Alzheimer's disease through systematic curation and annotation
    Mwesigwa, Savannah
    Dai, Yulin
    Enduru, Nitesh
    Zhao, Zhongming
    FRONTIERS IN GENETICS, 2025, 16
  • [46] Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores
    Leonenko, Ganna
    Baker, Emily
    Stevenson-Hoare, Joshua
    Sierksma, Annerieke
    Fiers, Mark
    Williams, Julie
    de Strooper, Bart
    Escott-Price, Valentina
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [47] Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
    Ganna Leonenko
    Emily Baker
    Joshua Stevenson-Hoare
    Annerieke Sierksma
    Mark Fiers
    Julie Williams
    Bart de Strooper
    Valentina Escott-Price
    Nature Communications, 12
  • [48] Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity
    Clark, Kaylyn
    Leung, Yuk Yee
    Lee, Wan-Ping
    Voight, Benjamin
    Wang, Li-San
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (01) : 1 - 12
  • [49] Polygenic score modifies risk for Alzheimer's disease in APOE ε4 homozygotes at phenotypic extremes
    Huq, Aamira J.
    Fulton-Howard, Brian
    Riaz, Moeen
    Laws, Simon
    Sebra, Robert
    Ryan, Joanne
    Renton, Alan E.
    Goate, Alison M.
    Masters, Colin L.
    Storey, Elsdon
    Shah, Raj C.
    Murray, Anne
    McNeil, John
    Winship, Ingrid
    James, Paul A.
    Lacaze, Paul
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [50] The Association between Polygenic Hazard and Markers of Alzheimer's Disease Following Stratification for APOE Genotype
    De Marco, Matteo
    Manca, Riccardo
    Kirby, Janine
    Hautbergue, Guillaume M.
    Blackburn, Daniel J.
    Wharton, Stephen B.
    Venneri, Annalena
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (07) : 667 - 679